Related Experiment Video
Updated: Jun 23, 2025

07:08
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
9.6K
Concurrent Amyotrophic Lateral Sclerosis and Huntington's Disease
Ryoma Takahashi1, Minori Furuta1, Kazuaki Nagashima1
1Department of Neurology, Gunma University Graduate School of Medicine, Japan.
Internal Medicine (Tokyo, Japan)
|June 19, 2024
Summary
Huntington's disease (HD), a neurological disorder, can present with severe weakness mimicking amyotrophic lateral sclerosis (ALS). This case suggests a potential link between CAG repeat expansion in the huntingtin gene and both conditions.
Area of Science:
- Neuroscience
- Genetics
- Neuromuscular Disorders
Background:
- Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder.
- Typical HD symptoms include chorea, psychiatric issues, and cognitive decline, usually without significant muscle atrophy.
- Amyotrophic lateral sclerosis (ALS) is characterized by progressive muscle weakness and motor neuron degeneration.
Purpose of the Study:
- To report a genetically confirmed case of Huntington's disease presenting with severe systemic weakness.
- To investigate the potential overlap and shared genetic mechanisms between Huntington's disease and amyotrophic lateral sclerosis.
Main Methods:
- Clinical case presentation of a patient with genetically confirmed Huntington's disease.
- Assessment of neurological symptoms, including motor neuron involvement.
- Review of previously reported cases with co-occurring HD and ALS.
Main Results:
- The reported patient with genetically confirmed HD exhibited progressive systemic weakness.
- Clinical findings indicated both upper and lower motor neuron involvement, consistent with ALS.
- Analysis of current and previous cases suggests a possible role for CAG repeat expansion in the huntingtin gene in the pathogenesis of both HD and ALS.
Conclusions:
- Huntington's disease can manifest with significant muscle weakness and motor neuron signs, mimicking ALS.
- The cytosine-adenine-guanine (CAG) repeat expansion in the huntingtin gene may be implicated in the development of both Huntington's disease and amyotrophic lateral sclerosis.
- Further research is warranted to elucidate the shared pathogenic pathways between these two devastating neurological disorders.
Related Concept Videos
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524
Cross-bridge Cycle
117.3K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.3K
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K

